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Structural data on mammalian proteins are
often difficult to obtain by conventional NMR
approaches because of an inability to produce
samples with uniform isotope labeling in bacte-
rial expression hosts. Proteins with sparse iso-
tope labels can be produced in eukaryotic hosts
by using isotope-labeled forms of specific
amino acids, but structural analysis then re-
quires information from experiments other
than nuclear Overhauser effects. One source
of alternate structural information is distance-
dependent perturbation of spin relaxation times
by nitroxide spin-labeled analogs of natural
protein ligands. Here, we introduce spin-
labeled analogs of sugar nucleotide donors for
sialyltransferases, specifically, CMP-TEMPO
(CMP-4-O-[2,2,6,6-tetramethylpiperidine-1-oxyl])
and CMP-4carboxyTEMPO (CMP-4-O-[4-car-
boxy-2,2,6,6-tetramethylpiperidinine-1-oxyl]). An
ability to identify resonances from active site
residues and produce distance constraints is
illustrated on a 15N phenylalanine-labeled ver-
sion of the structurally uncharacterized, a-2,6-
linked sialyltransferase, ST6Gal I.
INTRODUCTION
Structural determination of proteins by NMRmethods has
traditionally relied on the detection of large numbers of nu-
clear Overhauser effects (NOEs). Uniform labeling with
13C, 15N, and 2H provides the improved resolution neces-
sary for the assignment of sufficient numbers of reso-
nances to conduct an NOE-based structure determination
[1, 2]. The labeling is usually accomplished by expressing
proteins in bacterial hosts that efficiently utilize low-cost
13C- and 15N-enriched substrates. However, there are
many proteins for which bacterial expression is not prac-
tical. For example, proteins that require glycosylation for
proper folding or full activity are normally expressed in eu-
karyotic hosts that require supplementation with a nearly
complete set of labeled amino acids, some of which are
very expensive [3, 4]. This is not a small class of proteins.Chemistry & Biology 14, 4About 50% of mammalian proteins may be glycosylated
[5]. It is therefore important to consider alternate sources
of structural data that can be used with the sparse labels
introduced by expressing proteins in eukaryotic cells
grown on media supplemented with selected sets of
less expensive 15N-labeled amino acids [6]. One source
applicable to this type of labeling relies on paramagnetic
perturbation of labeled sites upon introducing nitroxide-
carrying probes that are either substrate mimics or are co-
valently attached to the protein itself [7–15]. Here, we
present a probe that mimics a sugar nucleotide binding
to the active site of a glycosyltransferase. The protein tar-
get is the structurally uncharacterized sialyltransferase,
ST6Gal I, a protein that is itself glycosylated [16]. The
sugar nucleotide mimicked is the sialic acid-carrying
CMP-NeuAc. The mimic is demonstrated to be useful in
identifying active site residues of sialyltransferases, and
the studies lay groundwork for more general applications
to glycosyltransferase structure.
The essential component of the nitroxide spin label we
chose is the chemically stable moiety TEMPO (2,2,6,6-tet-
ramethylpiperidine-1-oxyl). The nitroxide group contains
an unpaired electron that drastically increases the relaxa-
tion of neighboring protons due to the large magnitude of
the electron magnetic moment. The interactions between
electron and proton magnetic moments extend to 20 A˚, a
distancemuch longer than for proton-proton NOEs, which
are limited to distances of 6 A˚ or less [1, 2]. In more quan-
titative terms, when the nitroxide spin-labeled compound
binds to the protein target, the nuclei of protein residues
experience enhanced spin relaxation with a 1/r6 depen-
dence on the distance, r, between the nitroxide group and
the nuclear site [7–15]. Resonances are broadened, longi-
tudinal spin relaxation times are shortened, and crosspeak
intensity inmostmultidimensional experiments is reduced.
Here, we use a simple method for detecting spin relax-
ation enhancements that depends on intensity loss of
crosspeaks in 1H-15N HSQC spectra [7, 12, 13]. The loss
is primarily due to transverse relaxation of protons during
INEPT transfers to nitrogen and back, and intensity loss
can be directly correlated with the inverse sixth power of
the distance between the nitroxide group and the protons
giving rise to each crosspeak. The general procedure is to
acquire a spectrum of the protein with the spin-labeled li-
gand in its oxidized paramagnetic form, then reduce the
nitroxide to a diamagnetic species with an ascorbate
salt, and repeat the spectral acquisition under as identical09–418, April 2007 ª2007 Elsevier Ltd All rights reserved 409
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Spin-Labeled NMR Probes of a-2,6-SialyltransferaseFigure 1. Structure of the Natural Donor
CMP-NeuAc and Its Analog CMP-4Car-
boxyTEMPOconditions as possible. The difference in crosspeak inten-
sities between the oxidized and reduced spectra should
be directly attributable to effects of the nitroxide electron
spin. Crosspeaks from protons in the ligand-binding site
are easily identified, and distances to protons in more re-
mote sites can be estimated.
ST6Gal I (EC 2.4.99.1) was chosen as the target protein
for the development of new structural probes based on its
biological significance and its current lack of structural
characterization. ST6Gal I catalyzes the transfer of sialic
acid residues from its native donor, CMP-NeuAc, to termi-
nal galactose residues of oligosaccharides onmammalian
proteins. Variability in the addition of sialic acids to various
proteins is correlated with colon cancer, development of
brain tumors, and immune regulation in the human body
[17, 18].
ST6Gal I is a member of the family 29 glycosyltrans-
ferases as defined by the CAZY database (www.cazy.
org/CAZY/). This family has no structural representative
in the RCSB Protein Data Bank (www.rcsb.org/pdb/).
While the structures of two bacterial sialyltransferases,
CstII (EC 2.4.99.-) and D24PmST1 (EC 2.4.99.4; EC
2.4.99.6; EC 2.4.99.9), are known, the sequence of ST6Gal
I (over 321 amino acids) is only 11%and 15% identical, re-
spectively, to these proteins [19, 20]. ST6Gal I has two
consensus sites for N-glycosylation (both appear to be
used), and it is a type II membrane protein. Both its native
glycosylation and status as a membrane protein are likely
to have contributed to the lack of structural characteriza-
tion. The catalytic domain of ST6Gal I was, however,
cloned and expressed in mammalian cells as early as
1987 [21], and it is this domain that we focus on here.
While refolding of small amounts of insoluble protein ex-
pressed in E. coli has been reported recently [22], mam-
malian cell expression remains the preferred means of
producing a characterizable amount of active protein.
The lack of structural characterization and the difficulties
in bacterial host expression make ST6Gal I a prime target
for sparse isotopic labeling and use of distance con-
straints derived from paramagnetic spin relaxation
enhancement.410 Chemistry & Biology 14, 409–418, April 2007 ª2007 ElsevIn developingappropriateparamagnetic analogs,weuse
CMP-NeuAc (Figure 1), the sugar donor in the sialylation re-
action catalyzed by ST6Gal I, as a model. The spin label
might be introduced to either the nucleotide base or the
sugar ring. Previous studies involving the design of sialyl-
transferase inhibitors show that thecytidinenucleotidepor-
tion is more critical for tight binding to sialyltransferases
than the neuraminic acid residue [23]. Nucleotide base-
modified CMP-NeuAc analogs are not tolerated by a-2,6-
sialyltransferase, while sugar-modified analogs with deriv-
atization at C5, C8, or C9 of the neuraminic acid residue
show affinities for ST6Gal I [24]. Substitution of the proton
at C3 with fluorine leads to another potentially useful inhib-
itor of sialyltransferases [25]. Therefore, we initiated studies
in which TEMPO, the spin-labeled nitroxide moiety, would
be linked to the phosphate of CMP through its C4 carbon;
thus, TEMPO takes the place of the neuraminic acid in
CMP-NeuAc. The six-membered ring of TEMPO mimics
the six-membered ring of the neuraminic acid. The addi-
tionalmethyl groups at C2 andC6 in TEMPO sit in the posi-
tionsoccupiedbyC4substituentsand theC7-C8extension
of neuraminic acid, and the nitroxide replaces theC5 acetyl
group of neuraminic acid. To further examine the logic of
this replacement,CMP-TEMPOwasmodeled into thecrys-
tal structure of CstII, in which CMP-3FNeuAc occupies the
sugar donor site. There are no severe steric conflicts iden-
tified. However, there is a noticeable absence of a carboxyl
group that apparently interacts with positively charged
amino acids in the binding site. Therefore, we also synthe-
sizedCMP-4carboxyTEMPO (Figure 1), inwhicha carboxyl
group is attached to C4 of TEMPO and effectively mimics
the carboxyl attached to C2 of neuraminic acid. CMP-
4carboxyTEMPO is demonstrated here to be a goodmimic
of CMP-NeuAc and a useful structural probe for ST6Gal I.
RESULTS
Preparation of the Spin-Labeled Ligands
CMP-TEMPO, 1, and CMP-4CarboxyTEMPO, 2
The synthesis of TEMPO-phosphate derivatives of ste-
roids [26, 27], TEMPO-modified adenosine diphosphateier Ltd All rights reserved
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TEMPO Analogs of CMP-NeuAc
Key: (a) 30% H2SO4/NaCN, THF, < 15
C. (b)
27% HCl, H2O, 80
C. (c) CH2N2/Et2O, MeOH.
(d) (iPr)2NP(Cl)OCH2CH2CN, Et(iPr)2N,
CH2Cl2. (e) 1H-tetrazole, MeCN, 40C. (f)
t-BuOOH, MeCN. (g) DBU, THF. (h) NaOMe,
MeOH-H2O.derivatives [28, 29], and TEMPO-modified di- and tri-
deoxy adenylates [30] has been reported. While providing
important precedents, the present synthesis of two
TEMPO derivatives of CMP-NeuAc, 1 and 2 (Figure 2), is
based upon procedures reported for the synthesis of
CMP-NeuAc and its analogs [31–34].
The synthesis of 1 started from the available precursor,
3, while the synthesis of 2 required the preparation of inter-
mediate 10. Compound 10 was obtained from the com-
mercial 4-Oxo-TEMPO 7 through the known cyanohydrin
8 [35]. Hydrolysis of the nitrile group in strongly acidic con-
ditions [36] provided the acid 9 in which the nitroxide had
been reduced. After removal of excess HCl, the crude
product was transformed into its methyl ester with diazo-
methane and slowly reoxidized by air [37, 38] to the nitro-
xide 10, which was then purified. The easily prepared
phosphoramidite derivatives 4 and 11 [33] were reacted
with the primary hydroxyl of the known cytidine derivative
5 [31] in the presence of tetrazole [32]. The obtained inter-
mediate phosphites were directly oxidized with tBuOOH
to provide the phosphates 6 and 12, respectively, which
were then purified [32]. As expected, compound 12 was
obtained in a lower yield than compound 6, likely due to
the effect of steric hindrance in the intermediate 11. Care-
ful two-step deprotection of 6 and 12 followed a literature
procedure [32] to provide 1 and 2, respectively.
Determination of Binding Affinities for Spin-Labeled
Analogs
An IC50 was measured as 8.7 ± 0.1 mM for CMP-TEMPO
and 15–20 mM for its reduced form, while an IC50 was
measured as 1.7 ± 0.1 mM for CMP-4carboxyTEMPO
and 3.5 ± 0.1 mM for its reduced form. With the substrate
level (S) of 171 mM and a KM of 150 mM for CMP-NeuAc,
the KI for CMP-TEMPO (radical) was calculated as
4.07 mM by the formula (IC50) * KM/(KM + [S]) [39], and
that for CMP-4carboxyTEMPO (radical) was calculated
as 0.79 mM. A KI for CMP-4carboxyTEMPO was alsoChemistry & Biology 14, 4determined from a more extensive investigation of the
concentration dependence of activities. The KI was ex-
tracted by using a double-reciprocal Lineweaver-Burk
plot and was determined to be 0.75 ± 0.05 mM.
The improvement in affinity of roughly a factor of 5 upon
addition of the carboxyl group is consistent with predic-
tions based on expected favorable interactions between
the carboxyl group and residues in the active site of
ST6Gal I. The affinity for CMP-4carboxyTEMPO is in
a range that is expected to be useful in the observation
of paramagnetic enhanced relaxation.
Distance-Dependent Line Broadening of 15N HSQC
Spectra of ST6Gal I
ST6Gal I can be prepared with 15N enrichment in amide
sites of specific amino acids (L.M., J. Glushka, L.H. Stan-
ton, F.T., R.E. Collins, G. Wiley, Z. Gao, J.H.P., and
K.W.M., unpublished data). An HSQC spectrum of a
0.3 mM sample prepared with all phenylalanines labeled
is presented in Figure 3A. There are 16 phenylalanines in
the sequence of the catalytic domain of ST6Gal I, and
16 crosspeaks corresponding to the 16 labeled amide
sites are identifiable in Figure 3A. These crosspeaks are
not yet assigned to specific sites in the sequence, but
strategies are being developed to make these assign-
ments [40]. We can identify crosspeaks belonging to phe-
nylalanines near theCMP-NeuAc-binding site from pertur-
bation of resonances by the bound substrate, bound
substrate analogs, or bound product. These were first
identified by using the product, CMP. However, it is pref-
erable to use a substrate rather than product for compar-
ison to TEMPO analogs of CMP-NeuAc. The native sub-
strate CMP-NeuAc is unfortunately slowly hydrolyzed
during spectral acquisition, so we used a slowly hydro-
lyzed analog, CMP-3FNeuAc.
A spectrum in the presence of a 10-fold excess of
CMP-3FNeuAc is shown in Figure 3B. Unlike many exam-
ples of crosspeak perturbation in HSQC spectra by09–418, April 2007 ª2007 Elsevier Ltd All rights reserved 411
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Spin-Labeled NMR Probes of a-2,6-SialyltransferaseFigure 3. 1H-15N HSQC Spectra of 15N-Phe ST6Gal I in the Presence of CMP-NeuAc Analogs
(A–D) Comparison of 1H-15N HSQC plots of (A) 15N-Phe ST6Gal I, (B) 15N-Phe ST6Gal I with a 10-fold molar excess of CMP-3FNeuAc, and (C and D)
15N-Phe ST6Gal I with a 4-fold excess of CMP-4carboxyTEMPO (C) before and (D) after reduction with a 5-fold excess of ascorbate (relative to the
amount of CMP-4carboxyTEMPO). The crosspeaks experiencing changes due to binding dynamics and/or paramagnetic relaxation are boxed.nonparamagnetic ligands, the dominant effects are broad-
ening or reduction in crosspeak intensity rather than
changes in chemical shift. Thismay be the result ofmoder-
ately slowexchange, resulting in lifetimebroadeningof res-
onances. Substantial induced movement of protein seg-
ments upon binding of sugar nucleotides could produce
this effect, and this type of motion has been suggested in
the studies of several other glycosyltransferases [41].
CMP-TEMPO and CMP-4carboxyTEMPO appear to
have qualitatively similar effects as CMP-3FNeuAc on
the 15N HSQC of ST6Gal I (Figure 3), which indicates
that these analogs very likely bind to the active site with
virtually the same protein contacts as the native substrate.
Consistent with the difference in binding constants, a 5-
fold excess of CMP-TEMPO over CMP-4carboxyTEMPO
is required to produce similar levels of perturbation.
In one way, it is unfortunate that crosspeak broadening
and an intensity decrease, rather than crosspeak shifts,412 Chemistry & Biology 14, 409–418, April 2007 ª2007 Elsevare seen in the CMP-3FNeuAc spectrum. Multiple contri-
butions to peak broadening can complicate conversion
of broadenings to distances between nitroxide- and phe-
nylalanine-labeled sites for the CMP-4carboxyTEMPO
spectrum. Fortunately, it is clear that the peaks are more
severely perturbed in the presence of CMP-4carboxy-
TEMPO binding, even with reduced binding to the protein
because of its lower binding constant. Also, there is one
peak that completely disappears in the presence of
CMP-4carboxyTEMPO that was not perturbed by CMP-
3FNeuAc. Hence, there is certainly nitroxide-enhanced
transverse relaxation present in the presence of CMP-
4carboxyTEMPO.
Extraction of nitroxide-dependent paramagnetic effects
can be simplified through the use of a better control spec-
trum. This can be provided based on an ability to remove
the effects of paramagnetic perturbation by reduction of
the nitroxide to a hydroxylamine. In Figure 3D, oneier Ltd All rights reserved
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Spin-Labeled NMR Probes of a-2,6-SialyltransferaseTable 1. Relative Intensities of the Labeled Crosspeaks in 1H-15N HSQC Regions and Their Corresponding Distance
Estimates
Peak Labels 15N-Phe ST6Gal I With Spin Label No Spin Labela Distance (A˚)
1 1.153 ± 0.046 0.058 ± 0.048 0.374 ± 0.031 10.6–12.9
2 1.239 ± 0.046 0.000 ± 0.048 0.091 ± 0.031 <17.0
3 1.571 ± 0.046 0.562 ± 0.048 0.921 ± 0.031 14.3–15.5
4 1.178 ± 0.046 0.175 ± 0.048 0.440 ± 0.031 12.6–14.4
1H-15N HSQC regions are shown in Figure 3.
a Values are taken from the reduced form of CMP-4carboxyTEMPO at a concentration adjusted to compensate for the binding af-
finity difference between its oxidized form and reduced form.observes the partial reappearance of the perturbed reso-
nances of the protein when the nitroxide radical is reduced
by ascorbate salt. Changes in intensities between re-
duced and oxidized spectra (Table 1) can then be related
to distances between nitroxide- and phenylalanine-
labeled positions.
One must also control for the possibility of nonspecific
binding to secondary sites. The TEMPO moiety itself is
quite hydrophobic and may bind to hydrophobic patches
on the protein independently of active site interactions;
this can lead to some additional broadening of peaks.
To rule this possibility out, a spectrum in the presence of
an equivalent amount of 4-carboxy-4-hydroxyTEMPO
(10) was acquired. No significant crosspeak intensity
loss was observed in the spectrum.
Distance Restraints for Molecular Modeling
The difference in intensity of crosspeaks between HSQC
spectra of proteins in the presence and absence of
a spin-labeled ligand (actually the presence of oxidized
and reduced forms) can be used to estimate distances be-
tween the position of the nitroxide label in the active site
and the protons giving rise to particular crosspeaks. Dur-
ing the transfer and refocusing periods of the experiment,
the amide proton magnetization is in the transverse plane
and is undergoing intensity loss due to paramagnetic
relaxation. A number of authors have employed the follow-
ing equation to relate the intensity loss to distances be-
tween the nitroxide and particular protons [7, 12, 13]:
lnðInsl=IslÞ= f  t 

K=r6
  ð4tc + 3tc  ½1+u2Ht2c1Þ: (1)
Here, Isl and Insl are the peak intensities (measured as
peak volumes) of resonances with and without spin label
(presence of oxidized and reduced forms), respectively.
f is the fraction of protein carrying a ligand, and t
(9.52 ms) is the total time during the INEPT (insensitive nu-
clei enhanced by polarization transfer) and refocusing pe-
riods of the HSQC pulse sequence. K is a constant related
to spin properties of the system (K = 1/15*S(S + 1)g 2g2b2 =
1.233 1032 cm6s2), r is the distance between the nitro-
xide and a site giving rise to a crosspeak of interest, tc is
the effective correlation time for tumbling of the protein,
and uH (900 MHz* 2p) is the precession frequency forChemistry & Biology 14, 4the amide proton. Frequently, a scaling factor that would
relate the inverse sixth power of distance to the log of
the intensity ratio is calculated empirically by using
a known distance in the system. This eliminates the
need to independently determine factors appearing in
Equation 1.Unfortunately, ST6Gal I does not have a crystal
structure, and it is not possible to provide a known dis-
tance.We can, however, determine an appropriate scaling
factor by using the binding constant determined for the
analog (f = 57%), an estimate of the correlation time
from spin relaxation data (tc = 20 ns), and fundamental nu-
clear and electron spin constants. The distances resulting
from application of Equation 1 are reported in Table 1.
The distances we estimate for the perturbed reso-
nances are all less than 17 A˚ and well within the bounds
of the 25 A˚ radius expected for a 40 kDa protein. Only
an upper limit can be set for peak 2 because of its com-
plete disappearance in the presence of the spin label.
Weak intensity in the presence of the reduced spin label
also makes the uncertainly in the upper limit to the dis-
tance large. Best estimate distances for the other peaks
cluster between 10 and 15 A˚. The narrow range is the re-
sult of the steep 1/r6 distance dependence for which a var-
iation in intensity ratios by a factor of two leads to only
a 12% variation in distance. We can, in principle, expand
the range of sensitivity and improve measurements for
peak 2 by collecting data with different concentrations of
spin-labeled ligand.
DISCUSSION
The above-described results provide a clear demonstra-
tion that nitroxide spin-labeled compounds designed to
mimic natural ligands of proteins can be used to obtain
structural data on proteins that are difficult to characterize
by conventional methods. The data we present require
some additional steps before a protein structure can be
produced. Crosspeaksmust be assigned to specific sites,
and this must be done without the aid of experiments that
require uniform isotopic labeling. Appropriate methods
are being developed [40], but this will take some time.
Also, computational methods that use sparse constraints
to produce protein structures must be improved [8, 10,
13]. However, the availability of even a few distance09–418, April 2007 ª2007 Elsevier Ltd All rights reserved 413
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near the active site are important steps forward.
Prior to completion of a structure for ST6Gal I, we can
compare of our distance estimates to distances observed
in the crystal structure of related molecules. The bacterial
a-2,3-sialyltransferase CstII [19] provides one such com-
parison. There is very low sequence homology between
this protein and ST6Gal I, but programs such as Gen-
THREADER [42, 43] can predict reasonable sequence
alignment. Using this alignment and a model built with
MODELER [44], we can predict distances between the ni-
troxide of bound CMP-4carboxyTEMPO and phenylala-
nine amide protons.We find the closest four phenylalanine
amide protons to be 6.5, 7.8, 11.8, and 16.1 A˚ from the
nitroxide of CMP-4carboxyTEMPO. Considering that
one entry is given only as an upper limit, these distances
are not far off from those listed in Table 1. In principle,
the distances in Table 1 can be used to improve modeling
of the ST6Gal 1 structure once sequential assignments of
crosspeaks to specific sequential sites in the protein are
available.
We can also compare our distances to the rather exten-
sive sequence analysis that has been done for ST6Gal I
[45]. Large (L) and small (S) conserved sequence regions
have been implicated in binding of the sugar donor. These
regions contain three phenylalanines (one in the S motif
and two in L motif). This number compares favorably
with the number of crosspeaks perturbed in our experi-
ments (four). To our knowledge, our observations thus
provide someof the first structural validation of sequences
predicted to be involved in sugar nucleotide binding for
ST6Gal I.
SIGNIFICANCE
The procedures presented for the synthesis of our
spin-labeled CMP-NeuAc analogs produced useful
structural probes of ST6Gal I. The analogs are, of
course, applicable to other sialyltransferases. There
are some 411 sialyltransferases identified in the
CAZY database, and all are believed to use the same
CMP-NeuAc sugar donor. The synthetic approach is
also potentially applicable to the preparation of
probes for other glycosyltransferases. Here, there
are thousands of entries distributed among 87 fami-
lies, but there are only a few commonly used sugar do-
nors. This makes a limited set of spin-labeled com-
pounds broadly applicable to a large class of
structural problems.
Structure determination of uncharacterized pro-
teins from sparse label constraints is, as yet, not
widely practiced. However, the potential importance
in difficult structural problems, such as those involv-
ing membrane proteins [46] and multiprotein com-
plexes, is clearly recognized [47, 48]. New methods
for predicting structures from sparse constraints
have also begun to appear. These have used sparse
distance constraints from a variety of other sources,
including chemical crosslinking, backbone to back-414 Chemistry & Biology 14, 409–418, April 2007 ª2007 Elsevibone NOEs, and paramagnetic metal ion perturba-
tions [49–52], but distance constraints coming fromni-
troxide spin-labeled perturbations can be used in
a very similar way. Glycosylated proteins represent
a new structural challenge in which information from
sparse labels may be the only type of information ac-
cessible. Hence, the methods derived for structural
analysis of ST6Gal I, itself a glycosylated protein,
should find numerous applications to other proteins
in the future.
EXPERIMENTAL PROCEDURES
Synthesis of CMP-TEMPO, 1, and CMP-4CarboxyTEMPO, 2
General Procedures
Chemicals and dry solvents were purchased from Aldrich (USA). The
commercial 4-oxo-TEMPO was purified by chromatography (silica
gel, 82:18 hexanes:EtOAc). All moisture-sensitive reactions were per-
formed under an atmosphere of dry argon. Reactions were monitored
by TLC on silica gel Kieselgel 60 F254 (Merck) and were visualized un-
der UV light and by charring with a ceric ammonium molybdate re-
agent. All evaporations were performed under appropriate reduced
pressure at a bath temperature < 30C. Chromatography was per-
formed on silica gel Merck 70-230 mesh or, as indicated, on Iatro-
beads 6RS-8060 (60 mm, Bioscan), or, for reverse phase, on a Waters
preparative C18 WAT020594 column (125 A˚, 55–105 mm). All NMR
spectra of the TEMPO derivatives were acquired on Varian 300, 500,
or 600 MHz NMR spectrometers, in the indicated solvents, after addi-
tion of phenyl hydrazine as a reducing agent to the nitroxide sample
[53]. Mass spectra were obtained on an Applied Biosystems
Voyager-DE MALDI-TOF mass spectrometer by using DHB (2,5-
dihydroxybenzoic acid) as a matrix.
2-Cyanoethyl 1-Oxyl-2,2,6,6-Tetramethylpiperidin-4-yl N,N-
Diisopropyl Phosphoramidite, 4
For more information, see [33]. Diisopropylethylammine (297 mg,
2.30 mmol) was added to a solution of 4-hydroxy-TEMPO, 3
(198 mg, 1.15 mmol), and 2-cyanoethyl N,N-diisopropylchlorophos-
phoramidate (407 mg, 1.72 mmol) in dry CH2Cl2 (5 ml) cooled at 0
C
under an argon atmosphere. The mixture was then stirred for 1 hr at
room temperature until TLC (3:1 hexanes:EtOAc) indicated the com-
pletion of the reaction. The solvent was coevaporated with toluene,
and the residue was purified by flash chromatography (8 g Iatrobeads,
4:1:0.2% hexanes:EtOAc:NEt3) to afford 4 (164mg, 38%) as an orange
syrup (Rf 0.7, 3:1 hexanes:EtOAc). No NMR data are available for 4 due
to the rapid decomposition observed in the NMR tube after addition of
phenyl hydrazine. MS data are not available for 4 due to its instability in
the matrix.
2-Cyanoethyl (20,30-O,N4-Triacetylcytidin-50-yl) 1-Oxyl-2,2,6,6-
Tetramethylpiperidinyl-4-yl Phosphate, 6
For more information, see [32]. Compounds 4 and 5 [31] were sepa-
rately dried by coevaporating three times with dry toluene. Tetrazole
(1 ml of a 3% solution in MeCN) was slowly syringed into a mixture
of phosphoramidite, 4 (160 mg, 0.43 mmol), and the cytidine 5
(125 mg, 0.38 mmol) in MeCN (2 ml) at 0C. The reaction was followed
by TLC (95:5 CHCl3:MeOH) and seemed complete after stirring for
about 1 hr at room temperature. After the addition of three drops of trie-
thylamine, the solvents were coevaporated with toluene, providing an
orange material (0.30 g) that was used in the next step without purifi-
cation. A 5.5 M solution of tBuOOH in decane (0.47 ml) was slowly
added to the crudematerial (0.27 g) dissolved inMeCN (4ml) while stir-
ring in ice. The reaction was followed by TLC (95:5 CHCl3:MeOH). After
1 hr, the mixture was diluted with EtOAc and was washed with a satu-
rated NaHCO3 solution followed by brine. After drying overMgSO4, the
solvent was evaporated, and the residue was purified by chromatog-
raphy (5 g Iatrobeads, 97:3 CHCl3:MeOH) to afford the orange product,
6 (160 mg, 64%), as a 1:1 diastereoisomeric mixture (Rf 0.4, 95:5er Ltd All rights reserved
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1HNMR (500MHz, CD3OD) for the reduced form: d 8.13
(d, J = 7.0 Hz, 1H, H-6), 8.11 (d, J = 7.5 Hz, 1H, H-6), 7.48–7.40 (m, 2H,
23H-5), 6.03–6.02 (m, 2H, 23H-10), 5.52–5.44 (m, 4H, 23 2H of H-20
and H-30), 4.74–4.68 (m, 2H, 2 3 H-100), 4.48–4.41 (m, 4H, 2 3 2H
of H-40 and H-50), 4.40–4.33 (m, 2H, H-50), 4.30 (p, J = 6.5 Hz, 4H,
2 3 CH2CN), 2.95–2.86 (m, 4H, 2 3 OCH2CH2CN), 2.18 (s, 6H, 2 3
CH3CO), 2.10 (d, J = 2 Hz, 12H, 4 3 CH3CO), 2.10–2.01 (m, 4H, 2 3 2H
of H-300 and H-500), 1.70–1.61 (m, 4H, 2 3 2H of H-300 and H-500),
1.22–1.10 (m, 24H, 8 3 CH3); MALDI-TOF/MS: (M + Na
+) m/z 679.4,
calcd for C27H39N5O12PNa 679.2225.
CMP-TEMPO, 1
For more information, see [32]. 1,8-Diazabicyclo[5,4,0]-7-undecene
(DBU) (2.7 mg, 0.018 mmol) was added to a solution of the above-
describedmaterial, 6 (10mg, 0.015mmol), in THF (0.8ml), and themix-
ture was stirred at room temperature for 45 min until TLC (95:5
CHCl3:MeOH) indicated the completion of the reaction. A 5.4 M solu-
tion of NaOMe inMeOH (0.028ml, 0.15mmol) and then amixture of 1:2
MeOH:H2O (1.5ml) were added to thismixture. After stirring for 12 hr at
room temperature, the mixture was lyophilized, providing a residue
that was then loaded onto a small column of reverse-phase C18 eluted
with water to remove NaOH and NaOAc, and then run through a small
column of Bio-Rad AG 50W-X8 Na+ eluted with water to remove the
DBU byproduct. After freeze drying, the recovered material was puri-
fied by size-exclusion chromatography on Bio-Gel P2 (extra fine,
1.5 cm 3 45 cm, water, 4C) and lyophilization to provide CMP-
TEMPO, 1 (5.5 mg, 73%), as a yellow powder (5:2 iPrOH:0.5 M
AcOHNEt3, Rf 0.7; HPTLC RP-18 WF254S, Rf 0.2, water). 1H NMR
(500 MHz, CD3OD) for the reduced form: d 8.11 (d, J = 7.5 Hz,
1H, H-6), 5.99–5.96 (m, 2H, H-5 and H-10), 4.49–4.38 (m, 1H, H-100),
4.28–4.00 (m, 5H, H-30, H-50, H-20, H-40, and H-50), 1.80–1.71 (m, 2H,
H-300 and H-500), 1.56 (td, J = 3.5, 12.0 Hz, 2H, H-300 and H-500), 1.15
(s, 3H, CH3), 1.13 (s, 6H, 2 3 CH3), 1.09 (s, 3H, CH3);
31P NMR
(500 MHz, CD3OD, external standard H3PO4 = 0.00) d 0.72;
13C NMR
(500 MHz, CD3OD) for the reduced form: d 167.1 (C-2), 158.1
(C-NH2), 142.5 (C-6), 96.0 (C-5), 90.7 (C-1
0 ), 83.9 (d, J = 8.8, C-40),
75.9 (C-20 ), 70.2 (C-30), 68.8 (d, J = 6.0, C-400), 64.5 (d, J = 5.5, C-50),
59.6 (C-200 and C-600), 46.9 (d, J = 4.0, C-300/C-500), 46.8 (d, J = 4.0,
C-300/C-500), 32.2 (CH3), 20.4 (CH3); MALDI-TOF/MS for the reduced
form: (M + Na+) m/z 501.3, calcd for C18H31N4O9PNa 501.1721.
1,4-Dihydroxy 2,2,6,6-Tetramethyl-4-Piperidinecarboxylic
Acid, 9
For more information, see [36]. A solution of the cyanide 8 [35] (1.07 g,
5.35 mM) in 27% HCl (4.8 ml) was stirred for 2 hr at 80C. Coevapora-
tion with 80 ml water under reduced pressure (bath temperature <
30C) left an acidic, yellowish, oily solid that was left at 20C over-
night. The acidic supernatant was pipetted off, and the residual solid
was washed three times with ether and further dried in vacuo to yield
the crude N-hydroxyde 9 (750 mg). 1H NMR (300 MHz, D2O): d 2.38
(d, J = 14.9 Hz, 2H, H-3, and H-5), 2.20 (d, J = 14.9 Hz, 2H, H-3, and
H-5), 1.635 (s, 6H, 2 3 CH3), 1.428 (s, 6H, 2 3 CH3). MALDI-TOF/
MS: (M + Na+) m/z 240.1, calcd for C10H19NO4Na 240.1206. The
material, 9, was taken to the next step without further purification.
4-Hydroxy-4-Methoxycarbonyl-1-Oxyl-2,2,6,6-
Tetramethylpiperidine, 10
A solution of diazomethane in ether was added to a solution of crude 9
(750 mg) inMeOH (10ml) at 0C until the solution became deep yellow.
The mixture was then stirred in an open flask for 2 days [37, 38]. For-
mation of the nitroxide (upper spot) was followed by TLC (95:5
CHCl3:MeOH), and a small amount of N-hydroxyl starting material
remained untransformed. Purification by chromatography (20 g Iatro-
beads, 99:1 CHCl3:MeOH) gave 10, which was further purified by
crystallization from amixture of ether and hexanes at20C, providing
10 (684 mg, 55%) as orange crystals (Rf 0.4, 3:1 hexanes:EtOAc).
1H
NMR (300MHz, CD3OD) for the reduced form: d 3.71 (s, 3H, CH3OCO),
2.04 (d, J = 13.6 Hz, 2H, H-3, and H-5), 1.80 (d, J = 13.6 Hz, 2H, H-3,
and H-5), 1.35 (s, 6H, 23 CH3), 1.16 (s, 6H, 23 CH3); MALDI-TOF/MS
for the reduced form: (M + Na+) m/z 254.1, calcd for C11H21NO4Na
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For more information, see [33]. Diisopropylethylammine (168 mg,
1.30 mmol) was added to a solution of the above-described TEMPO
derivative, 10 (150mg, 0.65 mmol), and 2-cyanoethyl N,N-diisopropyl-
chlorophosphoramidate (231 mg, 0.98 mmol) in dry CH2Cl2 (2 ml)
cooled at 0C under an argon atmosphere. The mixture was then
stirred for 24 hr at room temperature until TLC (3:1 hexanes:EtOAc) in-
dicated the completion of the reaction. The solvent was coevaporated
with toluene, and the residue was purified by flash chromatography
(5 g Iatrobeads, 4:1:0.2% hexanes:EtOAc:NEt3) to afford 11 (240 mg,
86%) as a brown syrup (Rf 0.5, 3:1 hexanes:EtOAc).
1H NMR
(300 MHz, CD3OD) for the reduced form: d 3.77–3.66 (m, 4H,
OCH2CH2CN and 2 3 CH (CH3)2), 3.71 (s, 3H, CH3OCO), 2.67 (t, J =
5.9 Hz, 2H, CH2CN), 2.25–1.87 (m, 4H, H-3, and H-5), 1.33–1.12
(m, 24H, 8 3 CH3). No MS data are available for 11 due to its rapid
decomposition in the matrix.
2-Cyanoethyl 20,30-O,N4-Triacetylcytidin-50-yl 4-Carboxy-1-
Oxyl-2,2,6,6-Tetramethylpiperidin-4-yl Phosphate, 12
Formore information, see [32]. Compounds 5 [31] and 11were dried by
coevaporating two times with dry toluene. Tetrazole (0.7 ml, 0.45M so-
lution in MeCN) was then syringed into a mixture of phosphoramidite,
11 (80 mg, 0.186 mmol), and the cytidine 5 (75 mg, 0.203 mmol) in
MeCN (2.5 ml) cooled at 40C. After 5 min, the reaction mixture
was brought to room temperature and was stirred with one weight
equivalent of activated, crushed 3 A˚ molecular sieves for 2 hr. The re-
action was followed by TLC (9:1 EtOAc:MeOH). A 5.5 M solution of
tBuOOH in decane (0.8 ml) was then added directly to the crude mix-
ture at 0C. The reaction wasmonitored by TLC (9:1 EtOAc:MeOH). Af-
ter 1 hr, the mixture was diluted with EtOAc and washed with a satu-
rated NaHCO3 solution and brine. After drying over MgSO4, the
solvent was evaporated and the residue was purified by size-exclusion
chromatography on Sephadex LH-20 (2.53 45 cm) by using MeOH as
eluent to give the phosphate 12 (53 mg, 40%) as a 1:1 diastereomeric
mixture (Rf 0.3, 9:1 EtOAc:MeOH).
1H NMR (300 MHz, CD3OD) for the
reduced form: d 8.17 (d, J = 7.6 Hz, 1H, H-6), 8.16 (d, J = 7.6 Hz, 1H,
H-6), 7.49 (d, J = 7.5 Hz, 1H, H-5), 7.48 (d, J = 7.5 Hz, 1H, H-5), 6.06
(d, J = 6.3 Hz, 1H, H-10), 6.04 (d, J = 6.3 Hz, 1H, H-10), 5.51–5.48 (m,
4H, 2 3 2H of H-20 and H-30), 4.60–4.40 (m, 6H, 2 3 3H of H-40 and
H-50), 4.34 (q, J = 6.13 Hz, 4H, 23CH2CN), 3.79 (s, 6H, 23 CH3OCO),
2.89–2.86 (m, 4H, 23OCH2CH2CN), 2.22–2.06 (m, 8H, 23 4H of H-3
00
and H-500), 2.17 (s, 6H, 2 3 CH3CO), 2.10 (d, J = 1.9 Hz, 12H, 4 3
CH3CO), 1.33–1.29 (m, 12H, 4 3 CH3), 1.17 (s, 12H, 4 3 CH3);
MALDI-TOF/MS for the reduced form: (M + Na+) m/z 738.1, calcd for
C29H42N5O14PNa 738.2358.
CMP-4CarboxyTEMPO, 2
For more information, see [32]. 1,8-Diazabicyclo[5,4,0]-7-undecene
(14.7 mg, 0.096 mmol) was added to a solution of the above-described
material, 12 (53 mg, 0.074 mmol), in THF (0.8 ml), and the mixture was
stirred at room temperature for 1 hr until TLC (9:1 EtOAc:MeOH) indi-
cated the completion of the reaction. A 5.4 M solution of NaOMe in
MeOH (0.083 ml, 0.45 mmol) and then a mixture of 1:2 MeOH:H2O
(1.5 ml) were added to this mixture. After stirring for 9 hr at room tem-
perature, the mixture was lyophilized. The residue was loaded onto
a small column of reverse-phase C18, eluted with water to remove
NaOH and NaOAc, and then run through a small column of Bio-Rad
AG 50W-X8 Na+ eluted with water to remove the DBU byproduct. After
freeze drying, the recovered material was purified by size-exclusion
chromatography on Bio-Gel P2 (extra fine, 1.5 cm 3 45 cm, water,
at 4C) and lyophilization to provide CMP-4carboxyTEMPO, 2
(31 mg, 74%), as a yellow powder (5:2 iPrOH:0.5 M AcOHNEt3, Rf
0.5; HPTLC RP-18 WF254S, Rf 0.4, water).
1H NMR (600 MHz,
CD3OD) for the reduced form: d 8.22 (d, J = 7.8 Hz, 1H, H-6), 6.12 (d,
J = 7.8 Hz, 1H, H-5), 5.97 (d, J = 3.0 Hz, 1H, H-10), 4.39 (t, J =
5.5 Hz, 1H, H-30), 4.32–4.24 (m, 1H, H-50), 4.24–4.18 (m, 1H, H-50),
4.17–4.10 (m, 2H, H-20, and H-40), 2.51 (d, J = 14.6 Hz, 1H, H-300, or
H-500), 2.40 (d, J = 14.6 Hz, 1H, H-300, or H-500), 2.21 (t, J = 14.8 Hz,
2H, H-300, and H-500), 1.44 (d, J = 13.8 Hz, 6H, 2 3 CH3), 1.23 (s, 6H,409–418, April 2007 ª2007 Elsevier Ltd All rights reserved 415
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13C NMR (500 MHz, CD3OD) for the reduced form: d 181.6
(COOH), 167.2 (C-2), 158.1 (C-NH2), 142.8 (C-6), 96.1 (C-5), 90.9
(C-10), 84.0 (C-40), 76.0 (C-20), 69.6(C-30 ), 64.2 (C-50), 59.3 (C-200 and
C-600), 45.8 (C-300 and C-500), 31.6 (CH3), 22.8 (CH3);
31P NMR (500
MHz, CD3OD, H3PO4 external standard = 0.00) d 0.13; MALDI-TOF/
MS for the reduced form: (M + Na+) m/z 545.6, calcd for
C19H31N4O11PNa 545.1619.
Production of 15N-Phe ST6Gal I
An NH2-terminal His-tagged form of the rat ST6Gal I catalytic domain
(residues 97–403 from GenBank P13721) [21] was expressed in mam-
malian HEK293 cells in the pEAK expression vector (Edge Biosystems,
Gaithersburg, MD). Transfected cells were grown at 37C in DMEM
medium supplemented with 10% FBS and 1 mg/ml puromycin for an-
tibiotic selection. When the cells had grown to 70% confluency, they
were subcultured at a 1:5 ratio and grown to confluency in DMEMme-
dia depleted of Phe and supplemented with 2-fold excess (132 mg/L)
15N-Phe, 10% dialyzed FBS, and 1 mg/ml puromycin. After growth to
confluency, the culture media was harvested, and ST6Gal I was puri-
fied sequentially over Phenyl Sepharose, Ni-NTA, and Superdex-75
columns. The purified protein was stored in 20 mM Bis-Tris (pH 6.5),
200mMNaCl buffer. A detailed description of the recombinant ST6Gal
I expression in HEK293 cells, 15N-Phe labeling, and purification will be
published separately (L.M., J. Glushka, L.H. Stanton, F.T., R.E. Collins,
G. Wiley, Z. Gao, J.H.P., and K.W.M., unpublished data).
Activity and Inhibition Assays
The activity of ST6Gal I was determined by a radioactive assay based
on the transfer of [14C] sialic acid from a CMP-[14C] sialic acid donor to
an N-acetyllactosamine acceptor [54]. The buffer used in the assay
was sodium cacodylate (50 mM, pH 6.5) containing 0.1% (v/v) Triton
X-100 and 0.2 mg/ml BSA, and assays were performed at 37C for
15 min. The sialylated product was isolated by ion-exchange chroma-
tography on Dowex 1-X 8 (0.83 3 cm) columns and was counted with
a scintillation counter (BECKMAN LS 5000TD).
For IC50 measurements, reaction mixtures consisted of 2.1 mM
CMP-NeuAc, 9.2 nM CMP-[14C] NeuAc as tracer, 4.4 mM LacNAc
(N-acetyllactosamine), 11.1 nmol ST6Gal I, and inhibitor CMP-TEMPO
(0–17 mM) or CMP-4carboxyTEMPO (0–6 mM). For Ki measurement
on CMP-4carboxyTEMPO, another series of reaction mixtures was
prepared with 9.2 nM CMP-[14C] NeuAc, 4.4 mM LacNAc, 11.1 nmol
ST6Gal I, CMP-NeuAc (9–171 mM), and inhibitor (0, 0.8, 1.6, 2.4, and
3.2 mM) in a total volume of 60 ml. A KI was extracted by using a dou-
ble-reciprocal Lineweaver-Burk plot.
Collection of NMR Spectra
NMR samples were prepared in 10%D2O/90%Bis-Tris buffer (20mM)
at pH 6.5 with the protein concentration at 0.3 mM. The protein itself is
soluble to a higher level, but it appears to form dimers or higher oligo-
mers above this concentration, resulting in severe loss of signal. Spec-
tra were acquired on a Varian INOVA spectrometer operating at 900
MHz for protons. The spectrometer was equipped with a triple-
resonance cryogenic probe with z-pulsed gradient coils. Spectra
were run with the fast HSQC sequence supplied as part of the Varian
BioPak. Data were typically acquired with 11990 Hz as SW, 1800 Hz
as SW1, 48 indirect t1 complex points and 514 direct t2 complex
points, and a recycling rate of 1.5 s. Each spectrum represents a total
acquisition time of about 3 hr for 64 scans.
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